---
figid: PMC9108255__fimmu-13-752065-g006
figtitle: 'Small Molecule Agents Targeting PD-1 Checkpoint Pathway for Cancer Immunotherapy:
  Mechanisms of Action and Other Considerations for Their Advanced Development'
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC9108255
filename: fimmu-13-752065-g006.jpg
figlink: /pmc/articles/PMC9108255/figure/f6/
number: F6
caption: Two distinct mechanisms leading to functional antagonism with reported small
  molecule PD-L1 inhibitors.
papertitle: 'Small Molecule Agents Targeting PD-1 Checkpoint Pathway for Cancer Immunotherapy:
  Mechanisms of Action and Other Considerations for Their Advanced Development.'
reftext: Pottayil G. Sasikumar, et al. Front Immunol. 2022;13:752065.
year: '2022'
doi: 10.3389/fimmu.2022.752065
journal_title: Frontiers in Immunology
journal_nlm_ta: Front Immunol
publisher_name: Frontiers Media S.A.
keywords: PD-L1 inhibitors | cancer immunotherapy | mechanism of action (MOA) | small
  molecule immunomodulators | small molecule PD-1/PD-L1 inhibitors
automl_pathway: 0.9198739
figid_alias: PMC9108255__F6
figtype: Figure
redirect_from: /figures/PMC9108255__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9108255__fimmu-13-752065-g006.html
  '@type': Dataset
  description: Two distinct mechanisms leading to functional antagonism with reported
    small molecule PD-L1 inhibitors.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - CD274
  - SOD1
---
